Kelderman Kim has filed 31 insider transactions across 2 companies since February 2024.
Most recent transaction: a tax payment of 2303 shares of BIO-TECHNE Corp ($TECH) on November 03, 2025.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 3, 2025 | BIO-TECHNE Corp | $TECH | Kelderman Kim | Chief Executive Officer | F | Common Stock | 2303 | $62.57 | 48,665.0000 | 156,362,000 | 4.52% | 0.00% |
| Sept. 8, 2025 | CONMED Corp | $CNMD | Kelderman Kim | Director | A | Options To Purchase Common Stock | 6227 | $0.00 | 6,227.0000 | 31,150,000 | 9999.99% | 0.02% |
| Sept. 8, 2025 | CONMED Corp | $CNMD | Kelderman Kim | Director | A | RSUs (Restricted Stock Units) | 500 | $0.00 | 500.0000 | 31,150,000 | 9999.99% | 0.00% |
| Aug. 15, 2025 | BIO-TECHNE Corp | $TECH | Kelderman Kim | Chief Executive Officer | A | Performance Restricted Stock Units | 70708 | $0.00 | 140,265.0000 | 159,717,000 | 101.65% | 0.04% |
| Aug. 15, 2025 | BIO-TECHNE Corp | $TECH | Kelderman Kim | Chief Executive Officer | A | Restricted Stock Units | 35354 | $0.00 | 35,354.0000 | 159,717,000 | 9999.99% | 0.02% |
| Aug. 15, 2025 | BIO-TECHNE Corp | $TECH | Kelderman Kim | Chief Executive Officer | A | Stock Options (Right to Buy) | 90441 | $0.00 | 307,975.0000 | 159,717,000 | 41.58% | 0.06% |
| Aug. 15, 2025 | BIO-TECHNE Corp | $TECH | Kelderman Kim | Chief Executive Officer | M | Common Stock | 8543 | $0.00 | 55,273.0000 | 159,717,000 | 18.28% | 0.01% |
| Aug. 15, 2025 | BIO-TECHNE Corp | $TECH | Kelderman Kim | Chief Executive Officer | F | Common Stock | 4305 | $53.60 | 50,968.0000 | 159,717,000 | 7.79% | 0.00% |
| Aug. 15, 2025 | BIO-TECHNE Corp | $TECH | Kelderman Kim | Chief Executive Officer | M | Restricted Stock Units | 8543 | $0.00 | 17,087.0000 | 159,717,000 | 33.33% | 0.01% |
| July 22, 2025 | BIO-TECHNE Corp | $TECH | Kelderman Kim | Chief Executive Officer | M | Common Stock | 48176 | $44.33 | 90,379.0000 | 159,717,000 | 114.15% | 0.03% |
| July 22, 2025 | BIO-TECHNE Corp | $TECH | Kelderman Kim | Chief Executive Officer | F | Common Stock | 43649 | $53.12 | 46,730.0000 | 159,717,000 | 48.30% | 0.03% |
| July 22, 2025 | BIO-TECHNE Corp | $TECH | Kelderman Kim | Chief Executive Officer | M | Stock Option (Right to Buy) | 48176 | $0.00 | 251,204.0000 | 159,717,000 | 16.09% | 0.03% |
| July 15, 2025 | BIO-TECHNE Corp | $TECH | Kelderman Kim | Chief Executive Officer | M | Common Stock | 36132 | $44.33 | 75,136.0000 | 159,717,000 | 92.64% | 0.02% |
| July 15, 2025 | BIO-TECHNE Corp | $TECH | Kelderman Kim | Chief Executive Officer | F | Common Stock | 32933 | $51.42 | 42,203.0000 | 159,717,000 | 43.83% | 0.02% |
| July 15, 2025 | BIO-TECHNE Corp | $TECH | Kelderman Kim | Chief Executive Officer | M | Stock Option (Right to Buy) | 36132 | $0.00 | 299,380.0000 | 159,717,000 | 10.77% | 0.02% |
| Jan. 27, 2025 | BIO-TECHNE Corp | $TECH | Kelderman Kim | Chief Executive Officer | M | Stock Option (Right to Buy) | 13392 | $0.00 | 335,512.0000 | 160,626,000 | 3.84% | 0.01% |
| Jan. 27, 2025 | BIO-TECHNE Corp | $TECH | Kelderman Kim | Chief Executive Officer | S | Common Stock | 1661 | $77.95 | 39,004.0000 | 160,626,000 | 4.08% | 0.00% |
| Jan. 27, 2025 | BIO-TECHNE Corp | $TECH | Kelderman Kim | Chief Executive Officer | S | Common Stock | 11731 | $77.19 | 40,665.0000 | 160,626,000 | 22.39% | 0.01% |
| Jan. 27, 2025 | BIO-TECHNE Corp | $TECH | Kelderman Kim | Chief Executive Officer | M | Common Stock | 13392 | $37.70 | 52,396.0000 | 160,626,000 | 34.33% | 0.01% |
| Nov. 1, 2024 | BIO-TECHNE Corp | $TECH | Kelderman Kim | Chief Executive Officer | F | Common Stock | 2430 | $75.31 | 39,004.0000 | 161,115,000 | 5.86% | 0.00% |
| Aug. 29, 2024 | BIO-TECHNE Corp | $TECH | Kelderman Kim | Chief Executive Officer | M | Stock Option (Right to Buy) | 1492 | $0.00 | 348,904.0000 | 160,774,000 | 0.43% | 0.00% |
| Aug. 29, 2024 | BIO-TECHNE Corp | $TECH | Kelderman Kim | Chief Executive Officer | M | Common Stock | 1492 | $66.97 | 41,434.0000 | 160,774,000 | 3.74% | 0.00% |
| Aug. 15, 2024 | BIO-TECHNE Corp | $TECH | Kelderman Kim | Chief Executive Officer | A | Performance Restricted Stock Units | 51261 | $0.00 | 76,541.0000 | 160,774,000 | 202.77% | 0.03% |
| Aug. 15, 2024 | BIO-TECHNE Corp | $TECH | Kelderman Kim | Chief Executive Officer | A | Restricted Stock Units | 25630 | $0.00 | 25,630.0000 | 160,774,000 | 9999.99% | 0.02% |
| Aug. 15, 2024 | BIO-TECHNE Corp | $TECH | Kelderman Kim | Chief Executive Officer | A | Stock Options (Right to Buy) | 69061 | $0.00 | 217,534.0000 | 160,774,000 | 46.51% | 0.04% |
| July 31, 2024 | BIO-TECHNE Corp | $TECH | Kelderman Kim | Chief Executive Officer | M | Stock Option (Right to Buy) | 14000 | $0.00 | 350,396.0000 | 160,774,000 | 3.84% | 0.01% |
| July 31, 2024 | BIO-TECHNE Corp | $TECH | Kelderman Kim | Chief Executive Officer | F | Common Stock | 9479 | $81.97 | 39,942.0000 | 160,774,000 | 19.18% | 0.01% |
| July 31, 2024 | BIO-TECHNE Corp | $TECH | Kelderman Kim | Chief Executive Officer | M | Common Stock | 14000 | $37.70 | 49,421.0000 | 160,774,000 | 39.52% | 0.01% |
| Feb. 1, 2024 | BIO-TECHNE Corp | $TECH | Kelderman Kim | Chief Operating Officer | A | Restricted Stock Units | 9423 | $0.00 | 30,260.0000 | 160,060,000 | 45.22% | 0.01% |
| Feb. 1, 2024 | BIO-TECHNE Corp | $TECH | Kelderman Kim | Chief Operating Officer | A | Stock Options (Right to Buy) | 25945 | $0.00 | 168,113.0000 | 160,060,000 | 18.25% | 0.02% |
| Feb. 1, 2024 | BIO-TECHNE Corp | $TECH | Kelderman Kim | Chief Operating Officer | A | Stock Options (Right to Buy) | 51890 | $0.00 | 194,058.0000 | 160,060,000 | 36.50% | 0.03% |